Abstract | OBJECTIVE: METHODS: In this post hoc analysis from the nationwide observational CORONADO (Coronavirus SARS-CoV2 and Diabetes Outcomes) study, patients with T2D and a history of MBS were matched with patients without MBS for age, sex, and BMI either at the time of MBS or on admission for COVID-19. The composite primary outcome (CPO) combined invasive mechanical ventilation and/or death within 7 and 28 days following admission. RESULTS: Out of 2,398 CORONADO participants, 20 had a history of MBS. When matching for BMI at the time of MBS and after adjustment for diabetes duration, the CPO occurred less frequently within 7 days (3 vs. 17 events, OR: 0.15 [0.01 to 0.94], p = 0.03) and 28 days (3 vs. 19 events, OR: 0.11 [0.01 to 0.71], p = 0.02) in patients with MBS (n = 16) vs. controls (n = 44). There was no difference in CPO rate between patients with MBS and controls when matching for BMI on admission. CONCLUSIONS: These data are reassuring regarding COVID-19 prognosis in patients with diabetes and a history of MBS compared with those without MBS.
|
Authors | Claire Blanchard, Tanguy Perennec, Sarra Smati, Blandine Tramunt, Béatrice Guyomarch, Edith Bigot-Corbel, Lyse Bordier, Sophie Borot, Olivier Bourron, Cyrielle Caussy, Christine Coffin-Boutreux, Anne Dutour, Natacha Germain, Céline Gonfroy-Leymarie, Laurent Meyer, Gaëtan Prevost, Ronan Roussel, Dominique Seret-Bégué, Charles Thivolet, Bruno Vergès, Matthieu Pichelin, Pierre Gourdy, Samy Hadjadj, Matthieu Wargny, François Pattou, Bertrand Cariou, CORONADO investigators |
Journal | Obesity (Silver Spring, Md.)
(Obesity (Silver Spring))
Vol. 30
Issue 3
Pg. 599-605
(03 2022)
ISSN: 1930-739X [Electronic] United States |
PMID | 34586754
(Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 The Obesity Society. |
Chemical References |
|
Topics |
- Bariatric Surgery
- COVID-19
- Diabetes Mellitus, Type 2
- Humans
- RNA, Viral
- Retrospective Studies
- SARS-CoV-2
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|